New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report
Ischemic stroke is a complex multifactorial disorder. Anticoagulation is a growing research area, with the main goal of preventing systemic embolization and stroke. We report the case of a 41-year-old woman with antiphospholipid syndrome who was unsuccessfully treated with Dabigatran, a new oral ant...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-03-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1010-660X/55/3/71 |
| _version_ | 1797727574411968512 |
|---|---|
| author | Francesca Antonia Arcadi Simona Portaro Roberto Giorgianni Antonino Naro Carmela Casella Carmelo Genovese Silvia Marino Rocco Salvatore Calabrò |
| author_facet | Francesca Antonia Arcadi Simona Portaro Roberto Giorgianni Antonino Naro Carmela Casella Carmelo Genovese Silvia Marino Rocco Salvatore Calabrò |
| author_sort | Francesca Antonia Arcadi |
| collection | DOAJ |
| description | Ischemic stroke is a complex multifactorial disorder. Anticoagulation is a growing research area, with the main goal of preventing systemic embolization and stroke. We report the case of a 41-year-old woman with antiphospholipid syndrome who was unsuccessfully treated with Dabigatran, a new oral anticoagulant, as she developed a major stroke involving the right carotid artery, due to deep venous thrombosis with pulmonary embolism. We therefore suggest a closer monitoring of the safety and efficacy of dabigatran. Moreover, in the presence of multifactorial causes of pro-coagulation, we believe that warfarin should remain the mainstay of oral anticoagulation. |
| first_indexed | 2024-03-12T11:01:38Z |
| format | Article |
| id | doaj.art-99c46dec3233445ea521523887027f93 |
| institution | Directory Open Access Journal |
| issn | 1010-660X |
| language | English |
| last_indexed | 2024-03-12T11:01:38Z |
| publishDate | 2019-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-99c46dec3233445ea521523887027f932023-09-02T05:31:28ZengMDPI AGMedicina1010-660X2019-03-015537110.3390/medicina55030071medicina55030071New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case ReportFrancesca Antonia Arcadi0Simona Portaro1Roberto Giorgianni2Antonino Naro3Carmela Casella4Carmelo Genovese5Silvia Marino6Rocco Salvatore Calabrò7IRCCS Centro Neurolesi “Bonino-Pulejo”, 98123 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, 98123 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, 98123 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, 98123 Messina, ItalyStroke Unit, Policlinico Universitario, 98123 Messina, ItalyGenovese Laboratory Medicine and Pathology, 98050 Barcellona PG, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, 98123 Messina, ItalyIRCCS Centro Neurolesi “Bonino-Pulejo”, 98123 Messina, ItalyIschemic stroke is a complex multifactorial disorder. Anticoagulation is a growing research area, with the main goal of preventing systemic embolization and stroke. We report the case of a 41-year-old woman with antiphospholipid syndrome who was unsuccessfully treated with Dabigatran, a new oral anticoagulant, as she developed a major stroke involving the right carotid artery, due to deep venous thrombosis with pulmonary embolism. We therefore suggest a closer monitoring of the safety and efficacy of dabigatran. Moreover, in the presence of multifactorial causes of pro-coagulation, we believe that warfarin should remain the mainstay of oral anticoagulation.http://www.mdpi.com/1010-660X/55/3/71dabigatranwarfarinischemic strokeanticoagulants |
| spellingShingle | Francesca Antonia Arcadi Simona Portaro Roberto Giorgianni Antonino Naro Carmela Casella Carmelo Genovese Silvia Marino Rocco Salvatore Calabrò New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report Medicina dabigatran warfarin ischemic stroke anticoagulants |
| title | New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report |
| title_full | New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report |
| title_fullStr | New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report |
| title_full_unstemmed | New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report |
| title_short | New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report |
| title_sort | new versus old oral anticoagulants how can we set the scale needle considerations on a case report |
| topic | dabigatran warfarin ischemic stroke anticoagulants |
| url | http://www.mdpi.com/1010-660X/55/3/71 |
| work_keys_str_mv | AT francescaantoniaarcadi newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT simonaportaro newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT robertogiorgianni newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT antoninonaro newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT carmelacasella newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT carmelogenovese newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT silviamarino newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport AT roccosalvatorecalabro newversusoldoralanticoagulantshowcanwesetthescaleneedleconsiderationsonacasereport |